San Diego, CA, United States of America

Steffan Nicholas Ho

USPTO Granted Patents = 16 

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 371(Granted Patents)


Location History:

  • Menlo Park, CA (US) (1999 - 2002)
  • San Diego, CA (US) (2000 - 2020)

Company Filing History:


Years Active: 1999-2020

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steffan Nicholas Ho

Introduction

Steffan Nicholas Ho is an accomplished inventor based in San Diego, California. He boasts an impressive portfolio of 16 patents, which reflect his dedication to advancing the field of biotechnology. His innovative research has significant implications for the treatment of cancer, showcasing his ability to blend scientific inquiry with practical applications.

Latest Patents

Ho’s recent patents highlight his focus on cancer therapies. One notable patent describes a combination of a PD-1 antagonist and an ALK inhibitor for treating cancer. This innovation involves the use of therapies that target the Programmed Death 1 receptor (PD-1) and Anaplastic Lymphoma Kinase (ALK), which can enhance the efficacy of treatments for cancers that are positive for ALK, PD-L 1, or both. Another pivotal patent focuses on the regulated transcription of targeted genes and biological events, detailing a method for the inducible dimerization or oligomerization of intracellular proteins. This breakthrough is essential for understanding how proteins control cell signaling and activity, influencing various biological responses.

Career Highlights

Throughout his career, Steffan Nicholas Ho has collaborated with leading educational institutions, including Leland Stanford Junior University and Harvard College. His work at these prestigious institutions has bolstered his research and development capabilities, allowing him to contribute significantly to the field of cancer research.

Collaborations

Ho has worked closely with notable figures in his field, including Gerald R. Crabtree and Jeffrey P. Northrop. These collaborations have enabled the cross-pollination of ideas and techniques, further enriching his innovative contributions.

Conclusion

Steffan Nicholas Ho's journey as an inventor illustrates the intersection of scientific research and practical application in the realm of biotechnology. His latest patents not only expand the boundaries of cancer treatment but also underscore the importance of collaboration in pioneering advancements. With a strong base of patents and continued innovation, Ho remains a significant figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…